The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines

[1]  G. Derosa,et al.  The role of various peroxisome proliferator‐activated receptors and their ligands in clinical practice , 2018, Journal of cellular physiology.

[2]  G. Lazaridis,et al.  Protein expression patterns of cell cycle regulators in operable breast cancer , 2017, PloS one.

[3]  M. Bellomo,et al.  PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis , 2017, Front. Endocrinol..

[4]  T. Dinis,et al.  Anti-inflammatory protection afforded by cyanidin-3-glucoside and resveratrol in human intestinal cells via Nrf2 and PPAR-γ: Comparison with 5-aminosalicylic acid. , 2016, Chemico-biological interactions.

[5]  C. Cursiefen,et al.  Identification of Novel Endogenous Anti(lymph)angiogenic Factors in the Aqueous Humor. , 2016, Investigative ophthalmology & visual science.

[6]  V. Swope,et al.  Significance of the Melanocortin 1 and Endothelin B Receptors in Melanocyte Homeostasis and Prevention of Sun-Induced Genotoxicity , 2016, Front. Genet..

[7]  J. D'Orazio,et al.  Melanocortin 1 Receptor: Structure, Function, and Regulation , 2016, Front. Genet..

[8]  N. Myasoedov,et al.  Investigation of the effect of α-melanocyte-stimulating hormone on proliferation and early stages of differentiation of human induced pluripotent stem cells , 2016, Doklady Biochemistry and Biophysics.

[9]  M. Picardo,et al.  The role of WNT/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines , 2016, Oncotarget.

[10]  O. Bachs,et al.  p27Kip1 and p21Cip1 collaborate in the regulation of transcription by recruiting cyclin–Cdk complexes on the promoters of target genes , 2015, Nucleic acids research.

[11]  Z. Abdel‐Malek,et al.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation , 2014, Pigment cell & melanoma research.

[12]  C. Bai,et al.  Rosiglitazone Regulates Anti-Inflammation and Growth Inhibition via PTEN , 2014, BioMed research international.

[13]  H. Zhao,et al.  PPARγ-dependent pathway in the growth-inhibitory effects of K562 cells by carotenoids in combination with rosiglitazone. , 2014, Biochimica et biophysica acta.

[14]  E. Flori,et al.  Linking αMSH with PPARγ in B16‐F10 melanoma , 2013, Pigment cell & melanoma research.

[15]  Gautam Sethi,et al.  Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer , 2012, PPAR research.

[16]  Bernard A Roos,et al.  Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27. , 2011, Bone.

[17]  L. Nagy,et al.  PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation☆ , 2011, Biochimica et biophysica acta.

[18]  C. Bertolotto,et al.  Fifteen‐year quest for microphthalmia‐associated transcription factor target genes , 2010, Pigment cell & melanoma research.

[19]  P. Bahadoran,et al.  In vitro and in vivo anti-melanoma effects of ciglitazone. , 2009, The Journal of investigative dermatology.

[20]  Shunichi Takeda,et al.  Cyclin-dependent kinases and cell-cycle transitions: does one fit all? , 2008, Nature Reviews Molecular Cell Biology.

[21]  S. Bosari,et al.  High expression of PKA regulatory subunit 1A protein is related to proliferation of human melanoma cells , 2008, Oncogene.

[22]  E. Flori,et al.  Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress , 2007, Pigment cell & melanoma research.

[23]  C. Grommes,et al.  Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists , 2004 .

[24]  V. Keshamouni,et al.  Peroxisome proliferator-activated receptor-γ activation inhibits tumor progression in non-small-cell lung cancer , 2004, Oncogene.

[25]  V. Keshamouni,et al.  Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. , 2004, Oncogene.

[26]  C. Grommes,et al.  Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists. , 2004, The Lancet. Oncology.

[27]  D. Gilot,et al.  Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[28]  J. Kwak,et al.  Identification of a compound that directly stimulates phospholipase C activity. , 2003, Molecular pharmacology.

[29]  D. Ginty,et al.  Function and Regulation of CREB Family Transcription Factors in the Nervous System , 2002, Neuron.

[30]  T. Willson,et al.  Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662. , 2002, Biochemistry.

[31]  J. Auwerx,et al.  A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity. , 2001, Molecular cell.

[32]  R. Buscà,et al.  Cyclic AMP a key messenger in the regulation of skin pigmentation. , 2000, Pigment cell research.

[33]  M. Burger,et al.  Regulation of c-met expression in B16 murine melanoma cells by melanocyte stimulating hormone. , 1999, Journal of cell science.

[34]  G. Babcock,et al.  Activation of the cyclic AMP pathway by alpha-melanotropin mediates the response of human melanocytes to ultraviolet B radiation. , 1998, Cancer research.

[35]  K. Bille,et al.  Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product , 1996, The Journal of cell biology.

[36]  S. Boyce,et al.  Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Swope,et al.  Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens , 1992, Journal of cellular physiology.

[38]  P. Duray,et al.  Human melanocytes cultured from nevi and melanomas. , 1986, The Journal of investigative dermatology.

[39]  M. Eisinger,et al.  Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Pawelek.  Evidence suggesting that a cyclic AMP‐dependent protein kinase is a positive regulator of proliferation in Cloudman S91 melanoma cells , 1979, Journal of cellular physiology.

[41]  R. Halaban,et al.  The dual effect of melanocyte-stimulating hormone (MSH) on the growth of cultured mouse melanoma cells. , 1977, Experimental cell research.